Mendelsohn
Alfred Mendelsohn, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20100122833 | Multiphase Polymeric Composition Useful for Preparing Cable Insulation - Cable insulation layers having excellent mechanical and electrical properties are prepared from a composite free of plasticizer and comprising a heterogeneous, polymeric composition comprising (A) a polypropylene matrix, and (B) a propylene copolymer dispersed within the matrix and (i) comprising more than 80 weight percent (wt %) of units derived from propylene, and (ii) having a weight average particle size of less of than 1 micron (μm). The insulation layer is not only environmental friendly due to the lack of placticizer, but it also maintains its physical and operational integrity at temperatures of at least 90° C. | 05-20-2010 |
20110094772 | METHOD FOR PRODUCING WATER TREE-RESISTANT, TRXLPE-TYPE CABLE SHEATH - TRXLPE-type cable sheaths are prepared by a method in which a solid polymer is mixed with a liquid water tree-resistant agent either by dosing or direct injection. In the dosing method, the solid polymer, e.g., high pressure LDPE, is sprayed or otherwise contacted with the liquid agent, e.g., PEG, the agent is allowed to absorb into the polymer, and the polymer with absorbed agent is then fed to an extrusion apparatus for extrusion over a sheathed or unsheathed wire or optic fiber. In the direct injection method, the solid polymer is first fed to an extrusion apparatus, and the liquid agent is sprayed or otherwise contacted with the polymer before the two are blended with one another through the action of the mixing elements of the apparatus. | 04-28-2011 |
20140202732 | POWER CABLE DESIGN - The present invention is an improved power cable construction. | 07-24-2014 |
Brian A. Mendelsohn, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20080300192 | Auristatins Having an Aminobenzoic Acid Unit at the N Terminus - Auristatin-type peptides are disclosed which are highly cytotoxic, synthetically accessible, and can be conjugated to antibodies and other ligands. | 12-04-2008 |
Brian Alan Mendelsohn, Newcastle, WA US
Patent application number | Description | Published |
---|---|---|
20130190248 | SUBSTITUTED PEPTIDE ANALOGS - The present invention relates to peptide analogs, antibody-drug conjugates comprising such compounds, pharmaceutical compositions comprising such compounds and conjugates, and methods of treating cancer with such compounds and conjugates. | 07-25-2013 |
Frederick A.o. Mendelsohn, Carlton AU
Patent application number | Description | Published |
---|---|---|
20110021563 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF - The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions. | 01-27-2011 |
20120309787 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF - The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions. | 12-06-2012 |
Frederick A. O. Mendelsohn, Carlton AU
Patent application number | Description | Published |
---|---|---|
20130217726 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF - The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions. | 08-22-2013 |
John Mendelsohn, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20130059793 | EGF RECEPTOR MIMICKING PEPTIDES - Provided are peptides which can mimic the epidermal growth factor receptor (EGFR), e.g., by selectively binding TGF-α and/or EGF. In certain embodiments, the peptides are retro-inverted peptides. The peptides may be used as soluble decoys for TGF-α and/or EGF, and anti-cancer properties of peptides are demonstrated both in vitro and in vivo. The peptides may be administered alone or comprised in a fusion construct, imaging construct, and/or a therapeutic construct, e.g., for the treatment of a cancer. | 03-07-2013 |
Michael Mendelsohn, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20100323380 | METHODS FOR DIAGNOSING BLOOD VESSEL REOCCLUSION - The present invention features a method of diagnosing blood vessel reocclusion in a subject by detecting increased levels of sFLT-1 in a biological sample from the subject. | 12-23-2010 |
20130040838 | METHODS FOR IDENTIFYING THE PRESENCE OF A BICUSPID AORTIC VALVE - The present invention features a method for identifying a subject with a bicuspid aortic valve (BAV) by detecting one or more single nucleotide polymorphisms (SNPs) present in one or more BAV-associated chromosomal regions (e.g., chromosomal regions containing the AXIN1-PDIA2, ENG, BAT2/3, or ZNF385D gene(s)). | 02-14-2013 |
Steven Mendelsohn, Lindenhurst, NY US
Patent application number | Description | Published |
---|---|---|
20110147470 | Radiation dose exposure card - An apparatus for storing and informing health care professionals of patient's radiation exposures may comprise a radiation dosage history card, being a pre-printed card with a magnetic stripe. The card, having originating medical provider information preprinted thereon, may comprise one or more removably attached placards. A first removable placard may comprise a visual listing of a currently administered radiation dose and dosage date. A second removable placard may comprise a listing of: a year-to-date total radiation dosage, and a total tracked radiation dosage; while a third removable placard may comprise a list of each previous radiation dosage, treatment type, treating medical center, and date of said previous radiation dosage to comprise the total tracked radiation dosage. The placard data may be coordinated to match the data encoded upon the magnetic stripe. Data may be electronically mailed between present and previous medical providers to maintain an up-to-date universal exposure record. | 06-23-2011 |